IMMUNOTHERAPY WITH TUMOR-CELL SUB-POPULATIONS .2. THERAPY OF DRUG-RESISTANT L1210-LEUKEMIA AND EL4-LYMPHOMA

被引：3

作者：

KILLION, JJ

机构：

[1] OKLAHOMA MED RES FDN,PROGRAM CANC RES,OKLAHOMA CITY,OK 73104

[2] UNIV OKLAHOMA,HLTH SCI CTR,DEPT RADIOL SCI,OKLAHOMA CITY,OK 73104

来源：

关键词：

D O I：

10.1007/BF00199203

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：21 / 26

页数：6

共 21 条

[1]

CANTRELL JL, 1976, CANCER RES, V36, P3051

FIDLER, IJ ;

KRIPKE, ML .

[3]

FRIDBERG S, 1972, J NATL CANCER I, V48, P1463

[4]

GUTTERMAN JU, 1977, CANCER IMMUNOL IMMUN, V2, P1

[5]

HERSH EM, 1973, IMMUNOTHERAPY CANCER

[6]

HOSOKAWA M, 1975, CANCER RES, V35, P2657

[7]

HYMAN R, 1974, J NATL CANCER I, V52, P492

ISHIDATE, M ;

AOSHIMA, M ;

SAKURAI, Y .

JACOBS, DM ;

KRIPKE, ML .

[10]

KESSEL D, 1970, CANCER RES, V30, P2695